UK: The Importance Of Early Diagnosis In Cancer

Last Updated: 28 June 2018
Article by Amen Sanghera

Recently I read that cancer was discovered in a 1.7 million year old ancient human fossil.1 This discovery sparked my interest to understand some of the more recent developments in cancer research and the importance of early diagnosis in successfully treating cancers. Since the 1970s the survival rates for cancer have doubled, with 50 per cent of people diagnosed with cancer now surviving their disease for ten years or more.2

However, despite decades of research and considerable investment at a global level, cancer remains a pervasive challenge that will affect all of us in some way at some point in our lives. It is estimated that in the UK alone:

  • there are more than 360,000 new cancer diagnoses every year
  • there are around 164,000 cancer deaths every year
  • one in two of us will be diagnosed with cancer at some point in our life time up from one in three only five years ago
  • and around 4 in 10 UK cancer cases every year could be prevented.3 

These stats alone are startling. However, across the world cancer the incidence of cancer is increasing. In 2012 there were 14.1 million new cases of cancer, and in 2030 it is estimated that there will be 23.6 million new cases worldwide.4 We know that a key reason for the rising incidence rates is due to lifestyle choices such as smoking, poor diet and a lack of exercise. We also know that although cancer can occur at any age, the risk of developing cancer  increases with age, with half of all cancer cases in the UK each year diagnosed in people aged 70 or over.5 As life expectancy for people around the world increases the prevalence and incidence of cancers will also increase.

At the same time improvements in our ability to detect and treat cancers is resulting in more people living longer with cancer and many more people surviving it. Indeed, worldwide almost 32.5 million people diagnosed with cancer within the previous five years were still alive in 2012.6

Crucially important to improving cancer survival rates is the early detection and diagnosis of the disease. The more advanced the cancer the greater the difficulty in treating it successfully. For example:

  • nine in ten people diagnosed with stage one bowel cancer survive five years or more, whereas at stage four only one in ten survive
  • four in ten people diagnosed with stage one lung cancer survive five years or more, whereas at stage four only one in ten survive.

However, implementing and encouraging people to best utilise the services that are currently available for early diagnosis is complicated. For example, while the UK runs a number of national cancer screening programmes, these programmes are underutilised. Indeed, in 2017 the percentage of women participating in breast cancer screening was at the lowest level for a decade, dropping to 71 per cent of women.7

Our 2013 report, Working differently to provide early diagnosis, highlighted the compelling quality and cost arguments for improving access to early diagnostics and the organisational, financial, operational and cultural obstacles that needed to be addressed for the UK to improve the efficiency and effectiveness of its diagnostic services. Since our report, there have been numerous local and national initiatives aimed at improving access to earlier diagnosis. Some local examples include:

  • the use of mobile scanning trucks. In Manchester these trucks were able to pick up one cancer for every 33 patients scanned over one year8
  • in West London high resolution MR scanning reduced the average diagnosis time for prostate cancer from 56 days (following referral)  to eight days.9, 10 

However, to achieve faster and earlier cancer diagnoses at scale, NHS England is also looking to change the way it tackles cancer by introducing new models for care, rapid diagnosis centres, new diagnostic tests and cancer awareness campaigns. Some of these initiatives are occurring now while others are expected to be rolled out across England over the next three years. These initiatives include:

  • new models of care - in 2016 and over a period of two years, NHS England made more than £200m available to Cancer Alliances to help develop new models of care that will transform services by speeding up diagnosis. One such model, known as the Accountable Cancer Network (ACN), aims to deliver a coordinated approach to cancer care, looking at prevention and education as well as early diagnosis and treatment. The ACN serves a population of over ten million people and is led by three NHS foundation trusts; The Christie, The Royal Marsden and University College London Hospitals.
  • new diagnostics test - from 2018, NHS England will introduce a new bowel cancer screening test for over four million people. The faecal immunochemical test for haemoglobin (FIT) can be self-administered and is expected to increase the uptake of bowel cancer screening by around seven per cent. From April 2019 a new cervical cancer screening programme will be introduced, testing for Human papilloma virus (HPV) - the cause of 99 per cent of cervical cancers. The introduction of primary HPV testing for cervical cancer will see more than three million women a year tested and could prevent around 600 cases a year.
  • rapid diagnostic and assessment centres - the NHS Five Year Forward View Next Steps document calls for the introduction of ten new multidisciplinary rapid diagnostic and assessment centres across England. Currently nine out of the ten centres have been set up. The centres are composed of multidisciplinary clinical teams that specialise in the diagnosis of cancers and accept case referrals from GPs, hospitals doctors, radiologists and other health care professionals. Cancer Alliances are also establishing their own centres targeting specific cancers such as prostate.  The aim being to provide patients with faster and higher quality care, and ease diagnostic pressures on primary and secondary care services.
  • 28 day faster diagnosis standard - a new cancer diagnosis standard, designed to ensure that patients find out within 28 days whether or not they have cancer, will be introduced in 2020. Five sites are already piloting the new 28-day standard across six cancer specialties, including gynaecology, urology, head and neck, lung, lower and upper gastrointestinal.
  • developing the cancer workforce - in 2017 Health Education England (HEE) launched its 2021 Cancer workforce plan.11 The plan sets out how it will make sure the NHS has enough staff with the right skills to deliver improvements for people affected by cancer over the next three years. It also includes plans for the recruitment of additional specialist staff, including 200 extra clinical endoscopists and 300 reporting radiographers.12

While there is clearly widespread acknowledgement of the need to improve diagnostic services, early diagnosis remains an area that continues to challenge the NHS. While the NHS clearly has an important role, this is not just about the services that are available, but the timeliness and extent to which patients optimise their use of the services. As noted above, one in two of the population will experience cancer in their lifetime. The general public therefore needs to play its part and involve themselves in the discussion. We all need to work on removing the taboo of speaking about cancer, continue to educate ourselves on the symptoms and causes of common cancers and fully utilise the services that are available to us now.

Footnotes

1 https://www.newscientist.com/article/2099301-fossil-tumour-is-oldest-evidence-of-human-cancer-discovered-yet/

2 http://www.cancerresearchuk.org/health-professional/cancer-statistics/survival#heading-Zero

3 http://www.cancerresearchuk.org/health-professional/cancer-statistics-for-the-uk#heading-Three

4 https://www.cancer.gov/about-cancer/understanding/statistics

5 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/2014

6 http://www.cancerresearchuk.org/sites/default/files/cs_report_world.pdf

7 http://www.independent.co.uk/news/health/breast-cancer-screening-tests-lowest-level-decade-women-health-take-up-nhs-a8187156.html

8 https://www.england.nhs.uk/cancer/early-diagnosis/#models-care

9 https://prostatecanceruk.org/about-us/news-and-views/2017/12/new-data-shows-men-wait-four-times-longer-to-be-diagnosed-with-prostate-cancer-than-women-with-breast-cancer

10 https://www.england.nhs.uk/cancer/early-diagnosis/

11 https://hee.nhs.uk/our-work/cancer-workforce-plan

12 https://www.england.nhs.uk/cancer/early-diagnosis/

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions